PANACEA BIOTEC LIMITED Share Price & Technical Analysis
PANACEABIO · ₹359.7 (+0.76%)
Healthcare / Biotechnology
₹359.7
+0.76%
Panacea Biotec Limited, a biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally. The company operates through Vaccines and Pharmaceutical Formulations & Nutrition segments. Its product portfolio includes prescription products in various therapeuti…
Price chart
Seasonality
Oct has 3 positive and 2 negative years (last 5 years shown)
-1% return in Oct, 2% avg return in past 3 year Oct month.
14% return in 2026, 41% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -2% | -10% | -7% | 18% | 15% | 41% | -25% | -9% | -5% | -1% | – | – | 14% |
| 25 | -18% | -19% | 48% | 26% | -5% | -16% | -5% | 7% | -2% | 7% | -16% | 2% | 7% |
| 24 | -3% | -8% | -20% | 16% | -8% | 0% | 6% | 57% | 33% | 10% | 28% | -7% | 104% |
| 23 | -10% | -10% | -10% | 10% | -4% | 8% | 3% | 3% | 22% | -10% | 3% | 7% | 13% |
| 22 | 21% | -22% | -25% | 6% | -11% | -14% | -2% | 7% | -5% | 10% | -8% | 2% | -41% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Panacea Biotec Limited, a biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally. The company operates through Vaccines and Pharmaceutical Formulations & Nutrition segments. Its product portfolio includes prescription products in various therapeutic areas, such as diabetes, gastro-intestinal care, nephrology, oncology, orthopedics, pain management, and fever; cold and cough; and betacoronavirus, SARS-CoV-2, typhoid conjugate, pneumococcal conjugate, tetravalent dengue, and Mpox, etc. The company also offers health supplement products; and nutrition products under the ChilRun full, ChilRun 7+, and ChillRun No Sucrose brands. In addition, it engages in the real estate business. It exports its products to approximately 50 countries. It has collaboration agreements with the Russian Direct Investment Fund for producing Covid-19 vaccine, and Sputnik-V; and the Indian Council of Medical Research for clinical trials of DengiAll vaccine. Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹21.98B
P/E ratio
—
52W high
₹647.0
52W low
₹292.4
Volume
25,786
Beta
0.25
Related stocks in Healthcare
Frequently asked questions
- What is PANACEA BIOTEC LIMITED share price today?
- PANACEA BIOTEC LIMITED (PANACEABIO) last traded around ₹359.7 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does PANACEABIO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for PANACEABIO. Download the app for real-time alerts.
- How can I analyze PANACEA BIOTEC LIMITED stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.